Monitor the pace of ATM sales and any subsequent prospectus supplements for specific offerings. The company's cash burn rate and the timing of any debt or equity drawdowns will determine the actual dilution impact. The large shelf and high short interest suggest continued volatility.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 19 $7.31entry
- T+1 · 2d ago −5.47%α −1.83% · $6.91
- T+5 · in 5d Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
ClearPoint Neuro filed a universal shelf registration statement on Form S-3 to register up to $200M in securities, including a $100M at-the-market (ATM) equity offering program with Stifel. The filing also carries forward $76.8M in unsold securities from a prior shelf. The company has a $266M market cap, negative retained earnings, and has used four offering/registration filings in the last 24 months, signaling ongoing capital needs.
Key Financial Metrics
Key Facts
- Shelf registration for up to $200M in securities (common, preferred, debt, warrants, units)
- Includes a $100M ATM equity offering program with Stifel (3.0% commission)
- Carries forward $76.8M in unsold securities from prior S-3 (File No. 333-275476)
- Market cap of $266M; ATM alone represents ~38% of current market cap
- Net tangible book value of $7.4M ($0.23/share) as of Sep 30, 2026; after full ATM, dilution to new investors of $6.11/share at assumed $8.48 price
- Company has negative retained earnings and has relied on equity/debt financing; 4 offering/registration filings in last 24 months
- Short interest of 13.4% of estimated shares outstanding as of Oct 30, 2026
Financial Impact
Up to $200M in potential dilution; ATM alone could add up to ~11.8M shares (37% of current 32.1M outstanding) at $8.48/share
Risk Factors
- Significant dilution risk: full ATM usage would increase share count by ~37%
- Company has negative retained earnings and recurring capital needs; may need to access shelf aggressively
- High short interest (13.4%) could amplify price moves on ATM sales
- No minimum offering amount; actual proceeds and dilution uncertain
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001683168-26-008937 |
| Document: clearpoint_ex0405.htm | 0001683168-26-008937 |
| Document: clearpoint_ex107.htm | 0001683168-26-008937 |
| Document: clearpoint_ex0501.htm | 0001683168-26-008937 |
Track record
8 reports on CLPT
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +18.71% at T+5 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 18, 20263d ago 8-K Bearish 5/10 Entry $7.31 to $6.91 Now $6.91 +5.47% ▲ +5.47% +1.83% vs SPY
- Nov 18, 20263d ago S-3 Bearish 5/10 Viewing Entry $7.31 to $6.91 Now $6.91 +5.47% ▲ +5.47% +1.83% vs SPY
- Nov 16, 20265d ago Institutional Cluster Mixed 3/10 Entry $8.30 to $7.86 Now $6.91 −16.75% ▼ −5.30% −4.29% vs SPY
- Nov 3, 202618d ago SC 13G/A Bearish 5/10 Entry $10.16 to $8.69 Now $6.91 +31.99% ▲ +14.47% +10.06% vs SPY
- Oct 28, 202624d ago 8-K Bearish 6/10 Entry $10.69 to $10.67 Now $6.91 +35.36% ▲ +0.19% −1.59% vs SPY
- May 21, 202626w ago 8-K Neutral 3/10 Entry $11.44 to $11.82 Now $6.91 −39.60% ▲ +3.32% +2.74% vs SPY
- May 20, 202626w ago 144 Neutral 2/10 Entry $11.70 to $11.44 Now $6.91 −40.94% ▼ −2.22% −2.67% vs SPY
- May 13, 202627w ago 8-K Mixed 5/10 Entry $12.77 to $12.77 Now $6.91 −45.89% · 0.00% −0.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers